Excellent news, animal trials starting and to be finished early 2019.
"“The further we get down the road, the more viable the project becomes and the greater our chances are of securing a commercial partnership to bring it to market.... "
This strategy is much more conducive to shareholder value than the go it alone approach the old board followed with cardiocel
Ann: TAVR project progresses to animal trials, page-3
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.20 |
Change
-0.200(1.09%) |
Mkt cap ! $349.8M | |||
| Open | High | Low | Value | Volume |
| $18.50 | $18.50 | $18.00 | $77.59K | 4.263K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 206 | $18.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.70 | 34 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |